Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Mink Intersects 7.1 Meters of 0.44% Ni, 0.28% Cu, 0.06% Co in Massive Sulphide at Warren Property (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
LadRx Corporation (EM)
LADX
Healthcare
Biotechnology
LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the...
tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, Calif...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:LADX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(0)
•••
MissionIR
X
Post by
MissionIR
on Nov 04, 2013 6:54pm
CytRx Corp. (CYTR) Addressing Significant Medical Needs with
CytRx Corp. (CYTR) Addressing Significant Medical Needs with Four Key Initiatives on Deck CytRx is a biotech company focused on developing and commercializing the candidates in its oncology-focused
...more
(0)
•••
MissionIR
X
Post by
MissionIR
on Nov 01, 2013 4:32pm
CytRx Corp. (CYTR) Gets Positive Review in Seeking Alpha’s E
CytRx Corp. (CYTR) Gets Positive Review in Seeking Alpha’s Equity Stock Guru Article Oncological biopharm company CytRx today was featured in a Seeking Alpha article detailing the
...more
Drilling at Juby Gold Project Intersects 95.4 metres(m) at 1.36 g/t gold
posted Mar 11, 2026 9:00am by
McFarlane Lake Mining Ltd.
-
|
Drill hole GL 26-71 at Golden Lake has intersected 1.36 g/t gold over 95.4 metres, this includes 55.4 metres of 1.96 g/t gold and 9.9 metres of 3.22 g/t gold see Figure 2 and Tables 1 and 2 - HERE ...read more
(0)
•••
MissionIR
X
Post by
MissionIR
on Oct 31, 2013 8:15pm
CytRX Corp. (CYTR) Reports Further Developments in Global Ph
CytRX Corp. (CYTR) Reports Further Developments in Global Phase 2b Trial CytRX Corp., a biopharmaceutical research and development company specializing in oncology, today released further clinical
...more
(0)
•••
MissionIR
X
Post by
MissionIR
on Oct 29, 2013 6:57pm
CytRx Corp. (CYTR) Reports Q3 2013 Financial Results and Cli
CytRx Corp. (CYTR) Reports Q3 2013 Financial Results and Clinical Update CytRx Corp. today announced its financial results and clinical update for the quarter ended September 30, 2013. “Our
...more
(0)
•••
MissionIR
X
Post by
MissionIR
on Oct 28, 2013 6:44pm
CytRx Corp. (CYTR) – CEO Steven A. Kriegsman at the Helm
CytRx Corp. (CYTR) – CEO Steven A. Kriegsman at the Helm Los Angeles-based CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The company&
...more
(0)
•••
MissionIR
X
Post by
MissionIR
on Oct 25, 2013 8:02pm
CytRx Corp. (CYTR) Continues to Build Oncology Portfolio, He
CytRx Corp. (CYTR) Continues to Build Oncology Portfolio, Headed by Lead Candidate Aldoxorubicin CytRx is a biopharmaceutical research and development company with a particular focus on expanding its
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eshbal quickly expanding commercial and consumer footprint for gluten-free and health food brands
Freegold Ventures reports results from six additional drill holes at its Golden Summit project
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
Team spotlight: Q+A: Charlene Duffett, Viridian Metals exploration manager
Podcasts